Park H, Kim S, Rhee J, Kim HJ, Han JS, Nah SY, Chung C. Synaptic enhancement induced by gintonin via lysophosphatidic acid receptor activation in central synapses. J Neurophysiol 113: 1493-1500, 2015. First published December 10, 2014 doi:10.1152/jn.00667.2014 is one of the well-characterized, ubiquitous phospholipid molecules. LPA exerts its effect by activating G protein-coupled receptors known as LPA receptors (LPARs). So far, LPAR signaling has been critically implicated during early development stages, including the regulation of synapse formation and the morphology of cortical and hippocampal neurons. In adult brains, LPARs seem to participate in cognitive as well as emotional learning and memory. Recent studies using LPAR1-deficient mice reported impaired performances in a number of behavioral tasks, including the hippocampus-dependent spatial memory and fear conditioning tests. Nevertheless, the effect of LPAR activation in the synaptic transmission of central synapses after the completion of embryonic development has not been investigated. In this study, we took advantage of a novel extracellular agonist for LPARs called gintonin to activate LPARs in adult brain systems. Gintonin, a recently identified active ingredient in ginseng, has been shown to activate LPARs and mobilize Ca 2ϩ in an artificial cell system. We found that the activation of LPARs by application of gintonin acutely enhanced both excitatory and inhibitory transmission in central synapses, albeit through tentatively distinct mechanisms. Gintonin-mediated LPAR activation primarily resulted in synaptic enhancement and an increase in neuronal excitability in a phospholipase C-dependent manner. Our findings suggest that LPARs are able to directly potentiate synaptic transmission in central synapses when stimulated exogenously. Therefore, LPARs could serve as a useful target to modulate synaptic activity under pathological conditions, including neurodegenerative diseases. synaptic potentiation; lysophosphatidic acid receptor; ginseng; gintonin LYSOPHOSPHATIDIC ACID (LPA) is one of the well-characterized, ubiquitous phospholipids and exerts its effect by activating G protein-coupled receptors known as LPA receptors 1-5 (LPAR1-LPAR5; Choi et al. 2010) . A number of studies have shown that LPAR signaling plays a critical role during early development stages, including the regulation of synapse formation and the morphology of cortical and hippocampal neurons (Dubin et al.
synaptic potentiation; lysophosphatidic acid receptor; ginseng; gintonin LYSOPHOSPHATIDIC ACID (LPA) is one of the well-characterized, ubiquitous phospholipids and exerts its effect by activating G protein-coupled receptors known as LPA receptors 1-5 (LPAR1-LPAR5; Choi et al. 2010) . A number of studies have shown that LPAR signaling plays a critical role during early development stages, including the regulation of synapse formation and the morphology of cortical and hippocampal neurons (Dubin et al. 2010; Estivill-Torrús et al. 2008; Fukushima et al. 2000; Pilpel and Segal 2006 ). Even though the expression level of LPARs is known to decrease with age Choi et al. 2008; Chun 2005; Noguchi et al. 2009 ), LPA-mediated signaling seems to play important roles in aged animals, as well. Previously, LPAR1-deficient mice have been shown to exhibit impaired performance in a number of behavioral tasks, including the prepulse inhibition test (Harrison et al. 2003 ) and hippocampus-mediated spatial memory test (Dash et al. 2004) , and in pain sensation (Lin et al. 2012; Ueda 2011) . In addition, abnormal neurogenesis within the embryonic cerebral cortex as well as in the adult hippocampus have been reported in LPAR1-deficient mice . In a recent study, LPAR1 null mice showed impaired fear extinction that could be mimicked by using an LPAR1 antagonist in control animals, suggesting that LPAR1-mediated signaling plays a role in emotional expression (Pedraza et al. 2014) . However, the effect of LPAR activation in the synaptic transmission of central synapses after synapse maturation has not been investigated. This is possibly due to the expression of LPARs in the hippocampus being diminished after the completion of development. Additionally, no physiological agonist with high affinity to the LPARs expressed in mature hippocampus has been available. In the present study, we took advantage of gintonin, a novel ingredient isolated from ginseng, to activate LPARs and investigated the effect of their activation in hippocampal synapses.
Gintonin was recently identified as an active ingredient in ginseng, the root of Panax ginseng C.A. Meyer (Nah 2012) . Gintonin contains LPAs as well as ginseng major latex-like protein (GLP) and ginseng ribonuclease-like storage proteins (GSP). These proteins may function as an LPA carrier in ginseng, much as serum albumin does for LPA (Nah 2012) . Gintonin has been reported to activate G protein-coupled LPA but not sphingosine-1-phosphate (S1P) or other G proteincoupled fatty acid receptors, thereby inducing intracellular Ca 2ϩ ([Ca 2ϩ ] i ) transient through pertussis toxin (PTX)-sensitive and -insensitive G protein-phospholipase C (PLC)-inositol trisphosphate (IP 3 ) pathways ). This report indicated that gintonin acts as an extracellular signaling molecule to trigger specific LPAR-mediated cellular events. Therefore, we took advantage of gintonin as an extracellular agonist for LPA receptors to study physiological changes induced by LPAR activation in mature central synapses. We aimed to characterize the effect of gintonin and delineate its mechanism of action in acutely prepared hippocampal slices. We found that the activation of LPARs by application of gintonin acutely enhanced both excitatory and inhibitory transmission through tentatively distinct mechanisms. Gintonin-mediated LPAR activation primarily resulted in synaptic enhancement and an increase in neuronal excitability. Our findings suggest that LPARs are able to directly potentiate synaptic transmission in central synapses when stimulated exogenously. Therefore, LPARs could serve as a useful target for modulating synaptic activity under pathological conditions, including neurodegenerative diseases.
MATERIALS AND METHODS

Animals.
The animal protocols were approved by the Institutional Animal Care and Use Committee of the Konkuk University (Seoul, Korea; KU13143). Male Sprague-Dawley rats were purchased from Orient Bio (Gapyung, Korea). Animals were housed in groups with free access to food and water under standard conditions. Cages remained in a climate-and light-controlled environment (23 Ϯ 1°C, 12:12-h light-dark cycle with lights on at 0700, 45% humidity) for at least 4 days before the experiments. All efforts were made to minimize the number of animals used for experiments.
Gintonin preparation. Gintonin was prepared according to Pyo et al. (2011) . We used the crude gintonin fraction in the present studies without isolating further subtypes of gintonin because of their scarcity and because of the similar half-maximal effective dose (ED 50 ) values of the crude gintonin fraction in activation of endogenous LPA receptors in Xenopus oocytes (Pyo et al. 2011) .
Slice preparation. Male Sprague-Dawley rats 28 -35 days of age (Orient Bio) were anesthetized briefly with isoflurane. After immediate decapitation, their brains were stored in ice-cold dissection buffer (in mM: 212 sucrose, 3 KCl, 26 NaHCO 3 , 1.25 NaH 2 PO 4 , 7 MgCl 2 , and 10 glucose, gassed with 95% O 2 and 5% CO 2 ). Transverse slices (350 m thick) containing the hippocampus were prepared using a VT 1000S vibratome (Leica). Brain slices were transferred to a recovery chamber containing artificial cerebrospinal fluid (aCSF; in mM: 118 NaCl, 2.5 KCl, 1 NaH 2 PO 4 , and 26.2 NaHCO 3 , gassed with 95% O 2 and 5% CO 2 ) at 35°C for 1 h and stored at room temperature for recording. All experiments were performed at 27-30°C.
Electrophysiology. CA1 pyramidal neurons were voltage clamped to Ϫ60 mV in aCSF using Axopatch 200B and Clampex 10.3 (Molecular Devices) or HEKA ETC8 and pulse v8.8 (HEKA Electronik), filtered at 5 kHz and sampled at 10 kHz. Glass pipettes with a resistance of 2-6 M⍀ were used for voltage-clamp recording and were filled with an internal solution containing the following (in mM): 115 Cs-methanesulfonate, 20 CsCl, 10 HEPES, 2.5 MgCl 2 , 0.6 EGTA, 5 QX314, 4 Na 2 -ATP, 0.4 Na 2 -GTP, and 10 Na-phosphocreatine (pH 7.3). For current-clamp recording, the internal solution contained the following (in mM): 130 K-gluconate, 10 HEPES, 0.6 EGTA, 5 KCl, and 2.5 Mg-ATP (pH 7.3).
For recording of evoked transmissions, QX314 (5 mM)-containing internal solutions were used and the Schaffer collateral pathway was stimulated to elicit evoked excitatory postsynaptic currents (eEPSCs). The ionotropic GABAergic receptor antagonist picrotoxin (50 M, in DMSO; Sigma) was added to the aCSF to exclude GABA receptormediated synaptic transmission. eEPSCs were recorded at holding potentials of Ϫ60 mV for ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)-mediated transmission and ϩ40 mV for N-methyl-D-aspartate receptor (NMDAR)-mediated transmission. AMPAR-mediated responses were quantified as the peak amplitude measured at Ϫ60 mV, whereas NMDAR-mediated responses were quantified as the amplitude measured at 75 ms after stimulation to exclude possible AMPAR-mediated eEPSC contributions. To record evoked inhibitory postsynaptic currents (eIPSCs), 10 M 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 50 M 2-amino-5-phosphonovalerate (AP5) were added to the aCSF. Spontaneous EPSCs (sEPSCs) and IPSCs (sIPSCs) were recorded in the absence of field stimulation. Miniature EPSCs (mEPSCs) and IPSCs (mIPSCs) were recorded in the presence of 1 M TTX, 10 M CNQX, and 50 M AP5 or 1 M TTX and 50 M PTX, respectively. sEPSCs, sIPSCs, mEPSCs, and mIPSCs were analyzed manually to avoid false-positive and false-negative events by using Mini Analysis software (Synaptosoft).
Data analysis. Data were analyzed using Clampfit 10.3 (Molecular Devices) or Mini Analysis software (Synaptosoft). Values are means Ϯ SE, and n indicates the number of cells studied. Two-tailed unpaired or paired t-tests were used for statistical comparisons unless stated otherwise.
RESULTS
Gintonin enhances excitatory synaptic transmission in the adult hippocampus via LPAR activation. To examine the effect of gintonin on central synapses, we first examined whether direct gintonin application has any effect on synaptic transmission in hippocampal synapses. In these experiments, we measured eEPSCs from CA1 pyramidal neurons while stimulating Schaffer collateral pathways. Bath application of gintonin (6 g/ml) for ϳ10 min caused a remarkable potentiation of the peak amplitude of eEPSCs, suggesting that LPAR activation, presumably via gintonin application, enhances excitatory neurotransmission in central synapses (ϳ60% increase, n ϭ 24, P Ͻ 0.001; Fig. 1A ), whereas application of 0.05% DMSO for 10 min caused no changes in eEPSC amplitudes (n ϭ 11, P Ͼ 0.6; Fig. 1A ). The time course of gintonin's action on eEPSCs of a representative cell is plotted in Fig. 1B . The change in eEPSC amplitude was ϳ1.6-fold on gintonin application (P Ͻ 0.001 compared with DMSO group; Fig. 1A ), whereas we found no correlation between the initial amplitude of eEPSCs and the gintonin-induced enhancement in synaptic transmission (n ϭ 24, R 2 ϭ 0.002, P Ͼ 0.9, linear regression test; Fig.  1C ). To test whether the effect of gintonin observed in hippocampal synapses was through the activation of LPARs, we employed LPAR antagonists for the pharmacological blockade of different types of LPARs. These receptors are highly expressed in the hippocampus, and gintonin is known to have a high affinity for these receptor subtypes ). We bath-applied H2L56303 (10 M), an LPAR2 antagonist, or Ki16425 (200 M), an LPAR1 and LPAR3 antagonist, for 10 min preceding gintonin application while recording eEPSCs from hippocampal pyramidal neurons. In the presence of these antagonists, gintonin failed to increase the amplitude of eEPSCs (n ϭ 5-8, P Ͼ 0.1; Fig. 1 , D and E), indicating that gintonin indeed exerts its effect through the activation of LPARs. We found no meaningful changes via any antagonist application per se, suggesting that there is minimal activation of LPARs at rest in hippocampal synapses (n ϭ 5-8, P Ͼ 0.2; Fig. 1F ).
Gintonin-mediated potentiation of excitatory synaptic transmission. Previous studies using artificial LPAR expressing systems such as oocytes or B103 cells showed that gintonin increases Ca 2ϩ mobilization and NMDAR-mediated current through LPAR activation ). Thus we aimed to determine whether the synaptic enhancement induced by gintonin in hippocampal synapses shares cellular mechanisms, as reported in artificial expressing systems. To identify the origin of gintonin-induced potentiation, we tested whether gintonin would alter the release probability of presynaptic terminals or the composition of postsynaptic receptors. Upon two consecutive stimulations 50 ms apart, the ratio of peak amplitudes was calculated before and after the gintonin application. We found that gintonin application caused a remarkable decrease in the paired-pulse ratio, suggesting that the release probability of synaptic vesicles from presynaptic terminals was increased by LPAR activation (n ϭ 13, P Ͻ 0.001; Fig. 2A ). The decrease in the paired-pulse ratio of eEPSCs was observed in all the cells we recorded (n ϭ 13). To examine whether gintonin-induced LPAR activation causes any postsynaptic changes, we isolated AMPAR-mediated eEPSCs by measuring the peak amplitude at a holding potential of Ϫ60 mV, whereas isolated NMDAR-mediated eEPSCs were measured by averaging the peak amplitude during 50 -100 ms after the stimulation with a holding potential at ϩ40 mV. The bath application of gintonin induced a significant increase in the amplitude of AMPAR-mediated eEPSCs (n ϭ 13, P Ͻ 0.001) as well as NMDAR-mediated eEPSCs (P Ͻ 0.05; Fig. 2B ), whereas DMSO application induced no significant changes in the amplitude of either type of eEPSCs (n ϭ 9, P Ͼ 0.2; Fig. 2C ). There was no significant change in AMPAR/NMDAR-mediated currents, suggesting that both receptor-mediated currents are comparably enhanced on LPAR activation by gintonin (n ϭ 9 -13, P Ͼ 0.4; Fig. 2, B and C) . Taken together, our observations suggest that gintonin-induced LPAR activation readily enhances excitatory synaptic transmission via both presynaptic and postsynaptic mechanisms.
Gintonin enhances inhibitory neurotransmission through possibly separate mechanisms from its effect on excitatory neurotransmission. To examine whether LPAR-dependent augmentation of neurotransmission is selective to excitatory synaptic currents, we pharmacologically isolated eIPSCs and monitored their changes in peak amplitude while bath-applying gintonin (6 g/ml, 0.05% DMSO) (Fig. 3A) . As shown in Fig. 3A , LPAR activation by gintonin application caused the enhancement of an inhibitory component of synaptic transmission, as well (n ϭ 8, P Ͻ 0.001). The increase in eIPSC amplitudes was specific to gintonin application, because DMSO had a minimal effect on eIPSC amplitude (Fig. 3A) . Gintonin enhanced inhibitory neurotransmission by ϳ1.3 times compared with the peak amplitude before gintonin application (Fig. 3, A and C) . The time course of gintonin's action on eIPSCs of a representative cell is plotted in Fig. 3D . However, when we measured the paired-pulse ratio of the eIPSCs, no difference was observed on gintonin application compared with before the Fig. 1 . Gintonin enhances evoked synaptic transmission in central synapses. A: application of gintonin acutely increased the amplitude of evoked synaptic transmission measured in hippocampal pyramidal neurons compared with the amplitude before gintonin bath application (6 g/ml; n ϭ 24, ***P Ͻ 0.001). However, DMSO (0.05%) application as a control showed no effect on the amplitude of evoked excitatory postsynaptic currents (eEPSCs; n ϭ 11, P Ͼ 0.6). GT, gintonin. B: prolonged recording of eEPSC amplitude during the course of gintonin application is plotted every 30 s. C: initial eEPSC amplitude does not mediate the action of gintonin. Correlation between the degree of change (fold change) in eEPSC amplitude and initial eEPSC amplitude was negligible (n ϭ 24, Rgintonin application or on DMSO application (n ϭ 6 -10, P Ͼ 0.3; Fig. 3B ).
Next, we examined the effect of LPAR activation on spontaneous transmission. The frequency of both sEPSCs and sIPSCs was increased on gintonin bath application (n ϭ 13-21, P Ͻ 0.05), whereas the amplitude of sEPSCs and sIPSCs remained comparable (P Ͼ 0.2; Fig. 4A ). When we measured mEPSCs and mIPSCs, LPAR activation via gintonin did not cause any statistically significant changes in either frequency or amplitude (n ϭ 6 -10, P Ͼ 0.1; Fig. 4B ).
Given that activation of LPARs in central synapses could lead to a remarkable increase in both excitatory and inhibitory neurotransmission, we aimed to determine the net outcome of gintonin-mediated LPAR activation on synaptic transmission. For this, we measured the spontaneous spiking rate from CA1 neurons with no pharmacological blockade of any postsynaptic receptors. When compared before and after gintonin application, the spontaneous firing rate showed a significant increase on gintonin application (n ϭ 6, P Ͻ 0.05) but not DMSO application (n ϭ 6, P Ͼ 0.2; Fig. 4C ). These results suggest that although LPAR activation could lead to an increase in both excitatory and inhibitory synaptic transmission, the possible cellular mechanisms responsible for this enhancement may differ. When the activation of LPARs occurs at the same time, the enhancement for excitatory transmission could be predominant, thereby resulting in an overall increase in the firing rate of hippocampal neurons.
PLC activity mediates gintonin-induced enhancement of synaptic transmission. So far, we have shown that gintonin exerts its effect through activation of LPARs. LPARs are G q protein-coupled receptors and therefore initiate PLC-dependent signaling cascades. To delineate their underlying cellular mechanisms, we first targeted the PLC signaling pathway. When hippocampal slices were pretreated with a PLC inhibitor, 10 M U-73122, for 10 min, gintonin application no longer increased the amplitude of eEPSCs, suggesting that LPAR-mediated synaptic enhancement requires the activity of PLC (P Ͼ 0.1; Fig. 5A ). When the hippocampus was treated with a PLC inhibitor, there was a tendency toward a slight decrease in the amplitude of eEPSCs, suggesting the possible activation of PLC at rest. The effect of PLC inhibition at rest was nominal, however, because the changes caused by treatment with U-73122 only were statistically insignificant (P Ͼ 0.1; Fig. 5B ).
Previously, gintonin was reported to block the activity of voltage-gated potassium channels in a PLC-and tyrosine kinase activity-dependent manner in an artificial expressing system ). Thus gintonin-induced LPA receptor activation was expected to enhance neuronal excitability via the suppression of Kv channels. To examine this idea, we pretreated hippocampal slices with tetraethylammonium (TEA), a general voltage-gated potassium channel antagonist, before gintonin application. When voltage-gated potassium channels were blocked by TEA preincubation (20 mM, for 10 min), the bath application of gintonin no longer induced a prompt enhancement in the amplitude of eEPSCs (Fig. 5A ). This observation strongly suggests that the blockade of voltage-gated potassium channels is the major consequence of gintoninmediated LPAR activation, thereby increasing neuronal excitability in the hippocampus.
Gintonin-induced LPAR activation increases neuronal excitability of hippocampal neurons. Gintonin-induced LPAR activation increased the excitability of hippocampal neurons.
To measure the amount of current required to induce an action Fig. 2 . Gintonin-induced LPAR activation increases the release probability of CA1 pyramidal neurons. A: paired -pulse ratio (PPR; 50-ms interval of stimulation, average of 2nd amplitude/1st amplitude) was decreased on gintonin bath application (n ϭ 13, ***P Ͻ 0.001), whereas DMSO application did not alter the PPR (n ϭ 6, P Ͼ 0.8). B: gintonininduced LPAR activation increased the amplitudes of both AMPA receptor (AMPAR)-mediated eEPSCs (n ϭ 13, ***P Ͻ 0.001) and NMDA receptor (NMDAR)-mediated eEPSCs (*P Ͻ 0.05). The enhancement of both receptor-mediated currents was comparable because the ratio of AMPAR-to NMDARmediated eEPSCs (A/N ratio) was not changed on gintonin application (n ϭ 8, P Ͼ 0.8). C: DMSO application caused no significant changes in the amplitude of AMPAR-and NMDAR-mediated eEPSCs as well as the A/N ratio (n ϭ 9, P Ͼ 0.4). Representative recording traces are presented in insets to bar graphs (scale bars for all panels: 50 ms and 100 pA).
potential in response to brief depolarization, we gave a series of current steps of 50 pA each for 250 ms while patching a pyramidal neuron in the current-clamp configuration. Gintonin treatment lowered the amount of required current to elicit an action potential compared with that before gintonin treatment (Fig. 5C ), suggesting that LPAR activation facilitates the action potential generation of pyramidal neurons. Gintonin treatment caused slight depolarization in resting membrane potentials, presumably via suppression of Kv channels (Fig. 5C) .
The intrinsic excitability of pyramidal neurons in the hippocampus was evaluated before and after 10 min of gintonin application. We first measured the minimal amount of current required to elicit an action potential in response to brief depolarization (2 ms, 0 -750 pA, 10-pA steps). Gintonin application significantly reduced the amount of minimum current required to elicit an action potential (Fig. 5D ). In addition, the number of action potentials elicited at a given current injection was significantly increased, indicating that LPAR activation in the adult hippocampus indeed increases neuronal excitability. When we evaluated input resistance changes upon prolonged hyperpolarizing step current injections, no significant changes in input resistance were observed (Fig. 5E ). Taken together, our results suggest that gintonin, a novel exogenous agonist of LPARs, increases neuronal excitability as well as synaptic transmission via suppression of Kv channels and the PLCdependent signaling pathway.
DISCUSSION
In the present study, we took advantage of gintonin, an active compound of ginseng, to exogenously activate LPARs and made several key observations on the effect of gintonininduced LPAR activation on neurotransmission in central synapses. First, gintonin immediately potentiated both forms of synaptic transmission. Previously, it was shown that LPAR activation by gintonin application causes a Ca 2ϩ influx in artificially modified cells such as oocytes, B103 cells, or human umbilical vein endothelial cells (HUVECs). However, little is known about what kind of changes in synaptic transmission could occur upon gintonin-induced LPAR activation. In this study, we have shown that acute gintonin application enhances both excitatory and inhibitory neurotransmission. Second, gintonin-induced synaptic enhancement mainly relies on the LPAR signaling pathway, which is dependent on PLC activity as well as a potassium channel blockade. Third, even though LPAR activation seems to enhance both excitatory and inhibitory neurotransmission, the underlying mechanisms may differ. Finally, the overall outcome of gintonin-induced LPAR activation is to increase neuronal excitability, mainly due to a slightly depolarized resting membrane potential.
On careful examination with the use of an artificial expressing system, gintonin was shown to consist of LPAs and other ginseng proteins (Nah 2012) . Gintonin has been shown to increase transient [Ca 2ϩ ] i current through LPAR activation. In Fig. 3 . Evoked inhibitory synaptic transmission is potentiated on gintonin application. A: evoked inhibitory postsynaptic current (eIPSC) amplitude was increased on gintonin application (n ϭ 8, ***P Ͻ 0.001); however, DMSO did not potentiate the amplitude of eIPSCs (n ϭ 6, P Ͼ 0.8). B: bath applications of gintonin and DMSO did not alter the PPR of eIPSCs (50-ms interval stimulation; gintonin: n ϭ 10, P Ͼ 0.9; DMSO: n ϭ 6, P Ͼ 0.3). C: fold change in eIPSC amplitude on bath applications of gintonin or DMSO. Compared with DMSO, gintonin significantly increased the amplitude of eIPSCs (gintonin: n ϭ 13; DMSO: n ϭ 6; *P Ͻ 0.05). D: prolonged recording of eIPSC amplitude of a representative cell during the course of gintonin application is plotted every 30 s. Representative recording traces are presented in insets to bar graphs (scale bars for all panels: 20 ms and 100 pA).
the artificial expressing system, gintonin-mediated LPAR activation was suggested to be coupled to NMDA receptors . In the present study, we observed an increase in the amplitude of eEPSCs in agreement with previous studies showing an increase of Ca 2ϩ transients upon gintonin application. In addition, the effect of gintonin could be completely blocked by pretreatment with LPARs antagonists, as suggested previously. Therefore, in hippocampal neurons, gintonin could effectively activate LPARs and consequently increase synaptic transmission. However, in our study using hippocampal brain slices, we did not observe any particular enhancement of NMDAR-mediated currents. Minimal changes in the AMPAR/ NMDAR-mediated current ratio upon gintonin application were observed (Fig. 2) . The gintonin-induced enhancement of both AMPAR-mediated currents and NMDAR-mediated currents was comparable in hippocampal pyramidal neurons, leading to a remarkable increase in the amplitude of eEPSCs (Fig. 2) .
LPAR activation seems to enhance both excitatory and inhibitory neurotransmission. Interestingly, the underlying mechanisms responsible for synaptic enhancement may differ between excitatory and inhibitory transmission. The LPARmediated enhancement of excitatory transmission seems to depend on an increase in presynaptic release probability as well as on an increased surface expression of postsynaptic glutamate receptors. When we measured the paired-pulse ratio to monitor presynaptic changes, that of eEPSCs but not eIPSCs was decreased upon gintonin-mediated LPAR activation. All the cells we recorded exhibited a decrease in the paired-pulse ratio of eEPSCs, whereas 60% of cells showed a decrease in the paired-pulse ratio of eIPSCs. Therefore, the enhancement of inhibitory neurotransmission seems to largely rely on postsynaptic instead of presynaptic changes, possibly due to an increase in Cl Ϫ conductance (Pyo et al. 2011 ). These observations suggest that even though the activation of LPARs seems to potentiate both excitatory and inhibitory transmission, separate mechanisms are likely to be responsible for the LPARmediated enhancement of each neurotransmission in the hippocampus (Figs. 2 and 3) .
A series of pharmacological experiments delineated gintonin-mediated cellular events. Gintonin initially bound to LPARs, including LPAR1-3. A previous study suggested that the binding affinity of gintonin for LPAR subtypes is highest with LPAR2, and the Ca 2ϩ transient through LPAR1 or LPAR3 is PTX sensitive, whereas that through LPAR2 is PTX insensitive. Our results suggest that Ca 2ϩ transient through LPARs seems to be enough to readily potentiate synaptic transmission regardless of PTX sensitivity. Given that these LPARs are G q protein-coupled receptors, we further dissected the signaling pathway responsible for gintonin's ability to exert its effect. Indeed, the action of gintonin requires PLC activity. This observation is consistent with previous reports in artificial expressing systems Nah 2012; . The application of LPA agonists is also known to activate the LPAR4-mediated Rho-signaling pathway, thereby accumulating cAMP in cultured B103 cells, implying that LPAR4 could mediate gintonin-induced synaptic enhancement effects as shown with LPAR1-3 (Lee et al. 2007) .
Another interesting observation is that even though both excitatory and inhibitory transmission can be potentiated by gintonin application, the overall outcome of gintonin-induced LPAR activation is an increase in excitability, because the Fig. 4 . Gintonin-induced LPAR activation enhances spontaneous action potential (AP) firing of CA1 pyramidal neurons. A: fold change of spontaneous EPSCs (sEPSCs) frequency exhibited an increase on gintonin application (n ϭ 21, *P Ͻ 0.05), whereas the amplitude remained comparable (P Ͼ 0.2). The frequency of spontaneous IPSCs (sIPSCs) was significantly enhanced on gintonin application (n ϭ 13, *P Ͻ 0.05); however, the amplitude of sIPSCs was not changed (P Ͼ 0.5). B: gintonin application had minimal effect on spontaneous neurotransmission. The frequency and amplitude of miniature EPSCs (mEPSCs) or IPSCs (mIPSCs) showed no significant alteration on gintonin application (n ϭ 6 -7, P Ͼ 0.1; scale bars for A and B: 5 s and 50 pA). C: in a cell-attached recording configuration, spontaneous AP firing rate was increased on gintonin application (n ϭ 6, *P Ͻ 0.05), whereas DMSO had no effect (P Ͼ 0.2; scale bar: 500 ms).
spontaneous firing of action potentials is increased on LPAR activation by gintonin. The final effector of gintonin-mediated LPAR activation is likely to be the blockade of voltagedependent potassium channels. Previously, it was reported that the PLC-PKC pathway inhibits the action of voltage-dependent potassium channels (Boland and Jackson 1999; Levy et al. 1998) . In addition, a recent study showed that gintonin application in artificial expressing systems inhibits Kv 1.2 channels . We found that the resting membrane potential was slightly depolarized and that the threshold to induce action potentials was decreased upon gintonin application, consistent with previous studies in other systems. The blockade of voltage-dependent potassium channels with TEA occluded the synaptic enhancement mediated by gintonin-induced LPAR activation.
The increase in the neuronal excitability seems to be the primary effect of gintonin-induced LPAR activation. When we examined the effect of LPAR activation on spontaneous transmission, the frequency and amplitude of mEPSCs and mIPSCs did not exhibit any significant changes. Given our observations on paired-pulse ratio of eEPSCs ( Fig. 2A) , this was somewhat unexpected because the frequency of mEPSCs was anticipated to be increased. Instead, we observed an increase in the frequencies of sEPSCs and sIPSCs when cellular excitability changes could contribute to an increase in the network activity. These observations suggest that gintonin seems to be capable of enhancing release probability, because all the cells we recorded showed a decrease in the paired-pulse ratio; however, the principle effect of LPAR activation in mature hippocampus is possibly the increase in the neuronal excitability.
In a previous report, Dubin et al. (1999) showed that LPA exhibited neurotransmitter-like behavior by increasing both Cl Ϫ and nonselective cation currents in early embryonic cortical neuroblasts by day 11 (Dubin et al. 1999) . They further showed that the cell populations that were responsive to LPA for increase of Cl Ϫ or nonselective cation currents were different from each other. However, the question of what is the role of LPA-mediated stimulation on Cl Ϫ and nonselective cation currents in nervous systems was not clearly answered. In the present study, we could further observe that gintonin also mediates both inhibitory and excitatory neurotransmission in adult animals, although the final effect of gintonin in synaptic transmission seems to be excitatory in hippocampus. Thus the previous and present reports show the possibility that LPA could be a novel lipid-derived neurotransmitter that controls nervous systems in early development of brain as well as in adult brains. Lysophophatidylinositol (LPI) has been suggested as another example of a novel lipid neurotransmitter by a recent study (Sylantyev et al. 2013) . The action of LPI is similar to that of LPA, and it binds to the G protein-coupled receptor GPR55. In that study, the authors examined the synaptic effects of LPI on Schaffer collateral pathways and showed that LPI induced short-term synaptic potentiation. Furthermore, they demonstrated that LPI's effect was mainly mediated by presynaptic pathways and that bath treatment of LPI increased calcium levels in hippocampal neurons. Thus this study also suggests that lipid neurotransmitters could change synaptic activity in adult brains as gintonin does in the central nervous system (Sylantyev et al. 2013) . LPAR is a G q protein-coupled receptor that involves various downstream signaling molecules. A recent study reported the interaction of presynaptic LPAR2 with plasticity-related gene-1 (PRG-1) (Trimbuch et al. 2009), providing a possible mechanism by Fig. 5 . Gintonin increases neuronal excitability via the PLC-dependent signaling pathway and voltage-gated potassium (Kv) channel. A: gintonin's effect of evoking EPSCs was blocked in the presence of PLC and Kv channel antagonists U-73122 (10 M) and tetraethylammonium (TEA; 20 mM), respectively. Evoked EPSC amplitudes on pretreatment with antagonists were not increased by additional gintonin treatment (n ϭ 5-6, P Ͼ 0.1). B: fold change of eEPSC amplitudes after administration of PLC inhibitor and Kv channel blocker. Evoked EPSC amplitudes were not altered on application of these antagonists (n ϭ 5-6, P Ͼ 0.1; scale bars for A and B: 20 ms and 200 pA). C: depolarizing steps (250 ms, 50-pA increment, 11 steps) were given before and after gintonin application. The number of APs was increased in the 450-to 500-pA current injection steps after gintonin application (n ϭ 10-11, *P Ͻ 0.05; scale bar: 50 ms). In current clamp (inset), the resting membrane potential (V rest ) was decreased on gintonin treatment in both nonpaired and paired recordings (nonpaired: n ϭ 3-8, ***P Ͻ 0.01; paired: n ϭ 5, *P Ͻ 0.05). D: the threshold current (I threshold ) required to initiate an AP was decreased on gintonin application (n ϭ 10, *P Ͻ 0.05; scale bar: 10 ms). E: in hyperpolarizing steps (1 s, 25-pA decrement, 5 steps), input resistance was estimated on gintonin application. Input resistance in the gintonin-treated group was not altered on hyperpolarizing current injections (n ϭ 10, P Ͼ 0.2; scale bars: 100 ms and 10 mV).
which LPAR2 activation could modulate excitability of hippocampal neurons at a glutamatergic postsynaptic terminal.
Our observations suggest that LPARs, which are activated upon gintonin application, potentiate physiological activity of the hippocampus. In a previous study, LPA-induced Rhopathway activation in posttraining significantly enhanced longterm spatial memory (Dash et al. 2004) . Therefore, we suggest that gintonin-mediated enhancement in synaptic transmission could be instrumental to enhance learning and memory, as well.
In summary, our study suggests that LPARs engage in synaptic transmission in the adult brain. LPARs could be candidates for manipulating neuronal activity for the synaptic plasticity related to learning and memory. This could be a therapeutic target for alleviating memory loss and impaired cognition in human patients with neurodegenerative diseases. Further studies will need to directly address the effect of gintonin on synaptic plasticity and cognitive functions. 
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